PA Bill to Add Buprenorphine Prescribing Restrictions Revived

Authored by Dillon McClernon

Deni Carise, PhD, chief scientific officer for Recovery Centers of America, which is based in King of Prussia, Pennsylvania, says that energy being channeled to increasing oversight is misplaced and that the bill “creates unnecessary barriers to treatment at a time when we’re seeing an increase in opioid problems and fatal opioid overdose deaths.”

“It’s always so curious to me that physicians need any additional training and a special waiver to prescribe a treatment for opioid use disorder but never needed any special training, waivers, etc., to prescribe the opioids that put someone at risk for needing this treatment,” Carise tells Addiction Professional. “If there’s a lack of oversight, it the oversight needed to make sure medical students get the training needed in both adequately treating pain and understanding and evaluating substance use disorders.”

Read the full article on PA Bill to Add Buprenorphine Prescribing Restrictions Revived.

Authored by

Dillon McClernon

Dillon currently serves as the Senior Director of Sales and Marketing at RCA. After his tenure as Chief Communications Officer and senior advisor to RCA, he opted for a full-time position at RCA where he could build a new team linking sales and marketing to directly impact RCA’s mission of saving 1 million lives.